Author:
Tang Wen-xi,Shao Rong-jie,Wang Jingshu,Scherrer Emilie,Ma Ai-xia,Aguiar-Ibáñez Raquel
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference28 articles.
1. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Gershenwald;CA Cancer J Clin,2017
2. Cancer incidence and mortality in China, 2014;Chen;Chin J Cancer Res,2018
3. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases;Chi;BMC Cancer,2011
4. Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient’s choice: a multicentre Dermatologic Cooperative Oncology Group trial;Hofmann;Melanoma Res,2011
5. Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma;Eisen;Cancer,2010
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献